Peritoneal mesothelioma
Analysis of prognostic factors of patients with malignant peritoneal mesothelioma
8
Content validity and ePRO usability of the BPI-sf and “worst pain” item with pleural and peritoneal mesothelioma
10
Benign multicystic peritoneal mesothelioma: a case report
5
<p>Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations</p>
11
Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma
10
Ectopic ACTH secretion (EAS) associated to a well-differentiated peritoneal mesothelioma: case report
6
Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members
7
CpG oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts
8
Peritoneal Mesothelioma – A Review Concerning Surgical Management, Prognostic Factors, Future Advances and Our Experience in an Asian Population.
9
Anti-tumor activity of selective inhibitors of XPO1/CRM1- mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin
14
Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism
14
miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an “ALT-like” phenotype in diffuse malignant peritoneal mesothelioma cells
14
Effects of sex hormones on survival of peritoneal mesothelioma
7
Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy
6
Original Article Malignant peritoneal mesothelioma presented as peritoneal adenocarcinoma or primary ovarian cancer: Case series and review of the clinical and immunohistochemical features
7
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma
12
Distinctive clinical characteristics of malignant mesothelioma in young patients
8
Immunotherapy advances for mesothelioma treatment
80
Original Article Synchronous pleural and peritoneal malignant mesothelioma: a case report and review of literature
6
Pathology of mesothelioma
5